Literature DB >> 25757427

Treatable causes of cerebellar ataxia.

Adolfo Ramirez-Zamora1, Warren Zeigler, Neeja Desai, José Biller.   

Abstract

The cerebellar ataxia syndromes are a heterogeneous group of disorders clinically characterized by the presence of cerebellar dysfunction. Initial assessment of patients with progressive cerebellar ataxia is complex because of an extensive list of potential diagnoses. A detailed history and comprehensive examination are required for an accurate diagnosis and hierarchical diagnostic investigations. Although no cure exists for most of these conditions, a small group of metabolic, hereditary, inflammatory, and immune-mediated etiologies of cerebellar ataxia are amenable to disease-modifying, targeted therapies. Over the past years, disease-specific treatments have emerged. Thus, clinicians must become familiar with these disorders because maximal therapeutic benefit is only possible when done early. In this article, we review disorders in which cerebellar ataxia is a prominent clinical feature requiring targeted treatments along with specific management recommendations.
© 2015 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  ataxia; cerebellar syndrome; treatment

Mesh:

Year:  2015        PMID: 25757427     DOI: 10.1002/mds.26158

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  14 in total

Review 1.  Current concepts in the treatment of hereditary ataxias.

Authors:  Pedro Braga Neto; José Luiz Pedroso; Sheng-Han Kuo; C França Marcondes Junior; Hélio Afonso Ghizoni Teive; Orlando Graziani Povoas Barsottini
Journal:  Arq Neuropsiquiatr       Date:  2016-03       Impact factor: 1.420

2.  Primary Sjögren's syndrome (pSS)-related cerebellar ataxia: a systematic review and meta-analysis.

Authors:  Andreas Liampas; Antonios Nteveros; Konstantinos Parperis; Mohammed Akil; Efthymios Dardiotis; Elizabeth Andreadou; Marios Hadjivassiliou; Panagiotis Zis
Journal:  Acta Neurol Belg       Date:  2021-10-05       Impact factor: 2.396

Review 3.  Three Adult-Onset Autosomal Recessive Ataxias: What Adult Neurologists Need to Know.

Authors:  Jordan A Paulus-Andres; Melinda S Burnett
Journal:  Neurol Clin Pract       Date:  2021-06

4.  Rapid Eye Movement Sleep Behavior Disorder in Paraneoplastic Cerebellar Degeneration: Improvement with Immunotherapy.

Authors:  Thiago Cardoso Vale; Lucila Bizari Fernandes do Prado; Gilmar Fernandes do Prado; Orlando Graziani Povoas Barsottini; José Luiz Pedroso
Journal:  Sleep       Date:  2016-01-01       Impact factor: 5.849

5.  Cerebellar involvement in patients withprimary Sjögren's syndrome: diagnosis and treatment.

Authors:  Huaxia Yang; Yinghao Sun; Lidan Zhao; Xuan Zhang; Fengchun Zhang
Journal:  Clin Rheumatol       Date:  2018-01-29       Impact factor: 2.980

6.  Cerebellar ataxia with sensory ganglionopathy; does autoimmunity have a role to play?

Authors:  Panagiotis Zis; Ptolemaios Georgios Sarrigiannis; Dasappaiah Ganesh Rao; Nigel Hoggard; David Surendran Sanders; Marios Hadjivassiliou
Journal:  Cerebellum Ataxias       Date:  2017-12-22

7.  Cerebellar ataxia and sensory ganglionopathy associated with light-chain myeloma.

Authors:  Panagiotis Zis; Dasappaiah Ganesh Rao; Bart E Wagner; Lucinda Nicholson-Goult; Nigel Hoggard; Marios Hadjivassiliou
Journal:  Cerebellum Ataxias       Date:  2017-01-05

8.  Unmasking adrenoleukodystrophy in a cohort of cerebellar ataxia.

Authors:  Ying-Hao Chen; Yi-Chung Lee; Yu-Shuen Tsai; Yuh-Cherng Guo; Cheng-Tsung Hsiao; Pei-Chien Tsai; Jin-An Huang; Yi-Chu Liao; Bing-Wen Soong
Journal:  PLoS One       Date:  2017-05-08       Impact factor: 3.240

9.  Female sexual dysfunction associated with idiopathic cerebellar ataxia: A case report.

Authors:  Carmen López-Sosa; Jorge Gámez-Zapata; Helena Iglesias-de-Sena; Montserrat Alonso-Sardón
Journal:  BMC Womens Health       Date:  2019-11-07       Impact factor: 2.809

10.  Lipopolysaccharide administration for a mouse model of cerebellar ataxia with neuroinflammation.

Authors:  Jungwan Hong; Dongyeong Yoon; Youngpyo Nam; Donggun Seo; Jong-Heon Kim; Min Sung Kim; Tae Yong Lee; Kyung Suk Kim; Pan-Woo Ko; Ho-Won Lee; Kyoungho Suk; Sang Ryong Kim
Journal:  Sci Rep       Date:  2020-08-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.